BrainStorm Cell Therapeutics (BCLI)

Stock price history of BrainStorm Cell Therapeutics from 2003 to 2026

Annual Stock Price Performance

Year	Performance
2026	6.55%
2025	-73.88%
2024	-45.95%
2023	-83.83%
2022	-60.86%
2021	-11.89%
2020	9.95%
2019	23.70%
2018	-2.74%
2017	53.12%
2016	-13.90%
2015	-61.87%
2014	67.02%
2013	-25.00%
2012	-8.33%
2011	5.00%
2010	-26.92%
2009	225.00%
2008	-89.83%
2007	132.14%
2006	-49.09%
2005	-77.50%
2004	99.00%
2003	81.82%

Stock price for similar companies or competitors

Company	Stock price	Change 1d%	Country
Gilead Sciences GILD	A$186.79	3.01%	🇺🇸 USA
Cytokinetics CYTK	A$93.58	-1.35%	🇺🇸 USA
Seagen SGEN	A$342.06	-0.07%	🇺🇸 USA
Biogen BIIB	A$245.87	-2.46%	🇺🇸 USA
Agenus AGEN	A$4.99	-9.24%	🇺🇸 USA
Acceleron Pharma XLRN	A$267.30	0.00%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Stock price history for BrainStorm Cell Therapeutics (BCLI)